Literature DB >> 26623716

Application of diagnostic and treatment criteria for common variable immunodeficiency disorder.

Rohan Ameratunga1,2, Peter Storey2, Russell Barker1, Anthony Jordan2, Wikke Koopmans1, See-Tarn Woon1.   

Abstract

Common variable immunodeficiency disorder (CVID) is the most frequent symptomatic primary immune deficiency disorder in adults. It probably comprises a spectrum of polygenic disorders, with hypogammaglobulinemia being the overarching feature. While the majority of patients with CVID can be identified with relative ease, a significant proportion can present with minimal symptoms in spite of profound laboratory abnormalities. Here we discuss three patients who were presented to the Auckland Hospital immunoglobulin treatment committee to determine if they qualified for immunoglobulin replacement. Two were asymptomatic with profound laboratory abnormalities while the third patient was severely ill with extensive bronchiectasis. The third patient had less severe laboratory abnormalities compared with the two asymptomatic patients. We have applied four sets of published diagnostic and treatment criteria to these patients to compare their clinical utility. We have chosen these patients from the broad phenotypic spectrum of CVID, as this often illustrates differences in diagnostic and treatment criteria.

Entities:  

Keywords:  Common Variable Immunodeficiency; HGUS; diagnostic criteria

Mesh:

Substances:

Year:  2016        PMID: 26623716     DOI: 10.1586/1744666X.2016.1126509

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  10 in total

Review 1.  Common variable immune deficiency: Dissection of the variable.

Authors:  Charlotte Cunningham-Rundles
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

Review 2.  Immune deficiency in chronic rhinosinusitis: screening and treatment.

Authors:  Sergio E Chiarella; Leslie C Grammer
Journal:  Expert Rev Clin Immunol       Date:  2016-08-18       Impact factor: 4.473

Review 3.  Review: Diagnosing Common Variable Immunodeficiency Disorder in the Era of Genome Sequencing.

Authors:  Rohan Ameratunga; Klaus Lehnert; See-Tarn Woon; David Gillis; Vanessa L Bryant; Charlotte A Slade; Richard Steele
Journal:  Clin Rev Allergy Immunol       Date:  2018-04       Impact factor: 8.667

4.  [Immunodeficiency in chronic rhinosinusitis : An important and often underestimated cause].

Authors:  L Klimek; A Chaker; C Matthias; A Sperl; P Gevaert; P Hellings; B Wollenberg; M Koennecke; J Hagemann; J Eckrich; S Becker
Journal:  HNO       Date:  2019-09       Impact factor: 1.284

5.  Transient hypogammaglobulinaemia of infancy: many patients recover in adolescence and adulthood.

Authors:  R Ameratunga; Y Ahn; R Steele; S-T Woon
Journal:  Clin Exp Immunol       Date:  2019-07-22       Impact factor: 4.330

6.  Initial intravenous immunoglobulin doses should be based on adjusted body weight in obese patients with primary immunodeficiency disorders.

Authors:  Rohan Ameratunga
Journal:  Allergy Asthma Clin Immunol       Date:  2017-12-06       Impact factor: 3.406

7.  Assessing Disease Severity in Common Variable Immunodeficiency Disorders (CVID) and CVID-Like Disorders.

Authors:  Rohan Ameratunga
Journal:  Front Immunol       Date:  2018-09-28       Impact factor: 7.561

8.  Epistatic interactions between mutations of TACI (TNFRSF13B) and TCF3 result in a severe primary immunodeficiency disorder and systemic lupus erythematosus.

Authors:  Rohan Ameratunga; Wikke Koopmans; See-Tarn Woon; Euphemia Leung; Klaus Lehnert; Charlotte A Slade; Jessica C Tempany; Anselm Enders; Richard Steele; Peter Browett; Philip D Hodgkin; Vanessa L Bryant
Journal:  Clin Transl Immunology       Date:  2017-10-20

9.  The Natural History of Untreated Primary Hypogammaglobulinemia in Adults: Implications for the Diagnosis and Treatment of Common Variable Immunodeficiency Disorders (CVID).

Authors:  Rohan Ameratunga; Yeri Ahn; Richard Steele; See-Tarn Woon
Journal:  Front Immunol       Date:  2019-07-17       Impact factor: 7.561

10.  All Patients With Common Variable Immunodeficiency Disorders (CVID) Should Be Routinely Offered Diagnostic Genetic Testing.

Authors:  Rohan Ameratunga; Klaus Lehnert; See-Tarn Woon
Journal:  Front Immunol       Date:  2019-11-22       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.